Money Tree

The IPO: Lineage & Background

Bluedog Genetics won’t drop a full family tree, but let’s be real—this is the love-child of a dessert-scented sugar mama and a branchy workaholic dad who smells faintly of overtime. The result? A plant that doesn’t lean indica or sativa so much as it leans profitable. Expect two phenos: one compact enough for your closet IPO, one stretchy enough to high-five the ceiling fan.

Effects: Bull Market for Your Brain

At 19–21% THC, Money Tree won’t launch you into orbit, but it will put you in a low-risk mutual fund of giggles, mild creativity, and the sudden urge to alphabetize your snack drawer. The high starts like a sativa pep talk, then politely hands the mic to a mellow indica closer who just wants you to chill and count trichomes like sheep.

Flavor & Aroma: Portfolio Diversification

Nose ranges from sweet citrus futures to a spicy herbal index fund, depending on how hard you baby the VPD. Cured buds reek like someone spilled orange zest and clove cigarettes inside a cash vault. Translation: your roommate will know you’re holding before you even crack the jar.

Cultivation: Grow It Like You Hate Rent

Money Tree rewards the lazy capitalist: topping, trellising, and average feeding are enough to hit 1.5–2× stretch and respectable grams-per-watt. Handles high EC like a hedge-fund manager handles stress—grinning through the pain. Powdery mildew resistance is decent, but don’t test fate by turning your tent into a swamp.

Medical: Prescription for Adulting

Patients report relief from chronic doom-scrolling, low-grade existential dread, and that weird neck thing you get from hunching over spreadsheets. Anti-inflammatory terps also tackle headaches caused by reading the news or your crypto portfolio.

Who Should Invest?

Perfect for the grower who wants craft terps without craft drama, or the consumer who likes their weed functional and their bank account intact. If your idea of risk tolerance is ordering the second-cheapest wine, Money Tree is your spirit strain.